Top 5 Stock Picks of Srini Akkaraju and Michael Dybbs’ Samsara BioCapital

4. Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX)

Samsara BioCapital’s Stake Value: $36.3 million

Percentage of Samsara BioCapital’s 13F Portfolio: 5.69%

Number of Hedge Fund Holders: 16

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) is a Massachusetts-based biopharmaceutical company that develops clinical-stage drugs for the treatment of rare blood diseases and cancer.

According to the database of Insider Monkey, RA Capital Management has the most significant stake in Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) with 9.01 million shares worth $208.98 million, making up 2.89% of the portfolio. The second position is occupied by Boston-based Cormorant Asset Management with shares worth $109.46 in the third quarter of 2021.

According to the third quarter filings, Samsara BioCapital owned 1.56 million shares in Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) worth $36.3 million, representing 5.69% of the portfolio.